HeartBeam Insider Nelson Warwick Files Form 4, No Transactions Disclosed
| Field | Detail |
|---|---|
| Company | Nelson Kenneth Warwick III |
| Form Type | 4 |
| Filed Date | Mar 23, 2026 |
| Risk Level | low |
| Pages | 2 |
| Reading Time | 3 min |
| Sentiment | neutral |
Complexity: simple
Sentiment: neutral
Topics: insider-filing, administrative, no-transaction, form-4
TL;DR
**HeartBeam insider filed a Form 4, but it's just a status update, no trades to report.**
AI Summary
This Form 4 filing, dated March 23, 2026, indicates that Nelson Kenneth Warwick III, a reporting person for HeartBeam, Inc. (Issuer CIK: 0001779372), has filed a statement of changes in beneficial ownership of securities. While the filing confirms Warwick's reporting status and the company's details, it does not disclose any specific transactions (buys or sells) or changes in ownership. This matters to investors because Form 4s typically reveal insider trading activity, which can signal management's confidence (or lack thereof) in the company's future, but in this case, no such signal is provided.
Why It Matters
This filing confirms an insider's reporting status but lacks transaction details, meaning investors can't glean insights into recent insider buying or selling activity at HeartBeam, Inc.
Risk Assessment
Risk Level: low — This filing is purely administrative, confirming a reporting person's status without indicating any financial transactions or changes in ownership, thus posing no direct risk.
Analyst Insight
An investor should note that this filing is administrative and does not provide new information about insider trading activity. Therefore, it offers no direct actionable insight regarding buying or selling HeartBeam stock based on insider sentiment.
Key Players & Entities
- Nelson Kenneth Warwick III (person) — Reporting Person
- HeartBeam, Inc. (company) — Issuer
- 0001981293 (person) — CIK for Nelson Kenneth Warwick III
- 0001779372 (company) — CIK for HeartBeam, Inc.
- 2026-03-23 (date) — Filing Date
- 2026-02-09 (date) — Period of Report
FAQ
What is the purpose of this specific Form 4 filing by Nelson Kenneth Warwick III?
This Form 4 filing, dated March 23, 2026, is a 'Statement of changes in beneficial ownership of securities' for Nelson Kenneth Warwick III, a reporting person for HeartBeam, Inc. However, the provided text indicates it's primarily an administrative filing confirming his reporting status, as no specific transactions or changes in ownership are detailed within the given document snippet.
Which company is associated with Nelson Kenneth Warwick III in this filing?
Nelson Kenneth Warwick III is associated with HeartBeam, Inc. (Issuer CIK: 0001779372), a company incorporated in Delaware with a fiscal year end of December 31, operating in the Surgical & Medical Instruments & Apparatus sector (SIC: 3841).
Filing Stats: 670 words · 3 min read · ~2 pages · Grade level 8.3 · Accepted 2026-03-23 17:33:36
Filing Documents
- ownership.html (4)
- ownership.xml (4) — 4KB
- 0001213900-26-033029.txt ( ) — 5KB
From the Filing
SEC FORM 4 SEC Form 4 FORM 4 UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 Filed pursuant to Section 16(a) of the Securities Exchange Act of 1934 or Section 30(h) of the Investment Company Act of 1940 OMB APPROVAL OMB Number: 3235-0287 Estimated average burden hours per response: 0.5 Check this box if no longer subject to Section 16. Form 4 or Form 5 obligations may continue. See Instruction 1(b). Check this box to indicate that a transaction was made pursuant to a contract, instruction or written plan for the purchase or sale of equity securities of the issuer that is intended to satisfy the affirmative defense conditions of Rule 10b5-1(c). See Instruction 10. 1. Name and Address of Reporting Person * Nelson Kenneth Warwick III (Last) (First) (Middle) 2118 WALSH AVENUE, SUITE 210 15TH FL (Street) SANTA CLARA CALIFORNIA 95050 (City) (State) (Zip) UNITED STATES (Country) 2. Issuer Name and Ticker or Trading Symbol HeartBeam, Inc. [ BEAT ] 5. Relationship of Reporting Person(s) to Issuer (Check all applicable) X Director 10% Owner Officer (give title below) Other (specify below) 2a. Foreign Trading Symbol 3. Date of Earliest Transaction (Month/Day/Year) 02/09/2026 6. Individual or Joint/Group Filing (Check Applicable Line) X Form filed by One Reporting Person Form filed by More than One Reporting Person 4. If Amendment, Date of Original Filed (Month/Day/Year) Table I - Non-Derivative Securities Acquired, Disposed of, or Beneficially Owned 1. Title of Security (Instr. 3) 2. Transaction Date (Month/Day/Year) 2A. Deemed Execution Date, if any (Month/Day/Year) 3. Transaction Code (Instr. 8) 4. Securities Acquired (A) or Disposed Of (D) (Instr. 3, 4 and 5) 5. Amount of Securities Beneficially Owned Following Reported Transaction(s) (Instr. 3 and 4) 6. Ownership Form: Direct (D) or Indirect (I) (Instr. 4) 7. Nature of Indirect Beneficial Ownership (Instr. 4) Code V Amount (A) or (D) Price Common Stock 02/09/2026 A 17,241 A $ 0 144,388 D (1) Table II - Derivative Securities Acquired, Disposed of, or Beneficially Owned (e.g., puts, calls, warrants, options, convertible securities) 1. Title of Derivative Security (Instr. 3) 2. Conversion or Exercise Price of Derivative Security 3. Transaction Date (Month/Day/Year) 3A. Deemed Execution Date, if any (Month/Day/Year) 4. Transaction Code (Instr. 8) 5. Number of Derivative Securities Acquired (A) or Disposed of (D) (Instr. 3, 4 and 5) 6. Date Exercisable and Expiration Date (Month/Day/Year) 7. Title and Amount of Securities Underlying Derivative Security (Instr. 3 and 4) 8. Price of Derivative Security (Instr. 5) 9. Number of derivative Securities Beneficially Owned Following Reported Transaction(s) (Instr. 4) 10. Ownership Form: Direct (D) or Indirect (I) (Instr. 4) 11. Nature of Indirect Beneficial Ownership (Instr. 4) Code V (A) (D) Date Exercisable Expiration Date Title Amount or Number of Shares Explanation of Responses: 1. These securities are restricted stock units (RSUs). Granted on February 9, 2026 (the "Special RSU"), one half of the total number of shares of common stock ("Shares") subject to the Special RSU shall vest on March 31, 2026, the three-month anniversary of the vesting commencement date beginning on January 1, 2026, and the remaining Shares subject to the Special RSU shall vest on June 30, 2026, the six-month anniversary of the vesting commencement date. These RSUs have been issued from the Company's 2022 Equity Incentive Plan. /s/ Kenneth Warwick Nelson III 03/23/2026 ** Signature of Reporting Person Date Reminder: Report on a separate line for each class of securities beneficially owned directly or indirectly. * If the form is filed by more than one reporting person, see Instruction 4 (b)(v). ** Intentional misstatements or omissions of facts constitute Federal Criminal Violations See 18 U.S.C. 1001 and 15 U.S.C. 78ff(a). Note: File three copies of this Form, one of which must be manually signed. If space is insufficient, see Instruction 6 for procedure. Persons who respond to the collection of information contained in this form are not required to respond unless the form displays a currently valid OMB Number. * Form 4: SEC 1474 (03-26)